Thrombin Activity and Thrombin Receptor in Rat Glioblastoma Model: Possible Markers and Targets for Intervention?
暂无分享,去创建一个
J. Chapman | S. Harnof | Y. Mardor | D. Last | D. Daniels | Z. Zibly | E. Shavit-Stein | Z. Itsekson‐Hayosh | O. Gera | D. Bushi | David Góez | Z. Itsekson-Hayosh
[1] U. Hanisch,et al. Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling , 2014, Neurological research.
[2] J. Chapman. Coagulation in Inflammatory Diseases of the Central Nervous System , 2013, Seminars in Thrombosis & Hemostasis.
[3] M. Fehlings,et al. Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity , 2013, Journal of neurochemistry.
[4] Tao Jiang,et al. Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. , 2013, Cancer letters.
[5] M. Mrugala,et al. Advances and challenges in the treatment of glioblastoma: a clinician's perspective. , 2013, Discovery medicine.
[6] J. Uhm,et al. Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma. , 2013, Neuro-oncology.
[7] M. Merchant,et al. Thrombin-cleaved Fragments of Osteopontin Are Overexpressed in Malignant Glial Tumors and Provide a Molecular Niche with Survival Advantage* , 2012, The Journal of Biological Chemistry.
[8] J. Bernaudin,et al. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7. , 2012, Thrombosis research.
[9] R. Monteiro,et al. Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines. , 2012, Biochemical and biophysical research communications.
[10] H. Hamm,et al. Thrombin induces osteosarcoma growth, a function inhibited by low molecular weight heparin in vitro and in vivo , 2012, Cancer.
[11] XiaoNa Wei,et al. An Integrated Mathematical Model of Thrombin-, Histamine-and VEGF-Mediated Signalling in Endothelial Permeability , 2011, BMC Systems Biology.
[12] Zhi-cheng Yuan,et al. Upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 promotes the progression of human gliomas. , 2011, Pathology, research and practice.
[13] Q. Ye,et al. Thrombin is a therapeutic target for metastatic osteopontin‐positive hepatocellular carcinoma , 2010, Hepatology.
[14] S. W. Schneider,et al. The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells. , 2010, The Journal of investigative dermatology.
[15] S. Karpatkin,et al. Role of thrombin as a tumor growth factor , 2010, Cell cycle.
[16] José A Fernández,et al. Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1 , 2009, Thrombosis and Haemostasis.
[17] G. Reiser,et al. Protease-activated receptors in the brain: Receptor expression, activation, and functions in neurodegeneration and neuroprotection , 2007, Brain Research Reviews.
[18] H. Hamada,et al. Thrombin‐induced cell proliferation and platelet‐derived growth factor‐AB release from A172 human glioblastoma cells , 2007, Journal of thrombosis and haemostasis : JTH.
[19] J. Chapman. Thrombin in inflammatory brain diseases. , 2006, Autoimmunity reviews.
[20] V. Rumjanek,et al. On the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells , 2006, Journal of Thrombosis and Haemostasis.
[21] D. Gurwitz,et al. Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms. , 2005, Immunobiology.
[22] M. Mulholland,et al. Thrombin and PAR-1-AP increase proinflammatory cytokine expression in C6 cells. , 2005, The Journal of surgical research.
[23] S. Fisher,et al. Subnanomolar Concentrations of Thrombin Enhance the Volume-Sensitive Efflux of Taurine from Human 1321N1 Astrocytoma Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.
[24] J. Bockaert,et al. Constitutive Secretion of Protease Nexin-1 by Glial Cells and Its Regulation by G-Protein-Coupled Receptors , 2005, The Journal of Neuroscience.
[25] T. Schallert,et al. The role of thrombin in gliomas , 2005, Journal of thrombosis and haemostasis : JTH.
[26] D. Gurwitz,et al. Increased thrombin inhibition in experimental autoimmune encephalomyelitis , 2005, Journal of neuroscience research.
[27] D. Brat,et al. Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes , 2004, Experimental Neurology.
[28] F. Fiorino,et al. Thrombin and PAR‐1 acitvating peptide increase iNOS expression in cytokine‐stimulated C6 glioma cells , 2001, Journal of neurochemistry.
[29] M. D. Del Bigio,et al. Acute Tissue Damage After Injections of Thrombin and Plasmin into Rat Striatum , 2001, Stroke.
[30] D. Gurwitz,et al. Quantitative measurements of mouse brain thrombin-like and thrombin inhibition activities , 2001, Neuroreport.
[31] T. Kubota,et al. Production of amyloid beta protein precursor as a proteinase inhibitor by human astrocytic tumors. , 1999, Anticancer research.
[32] E. Komives,et al. Mechanism of Thrombin Clearance by Human Astrocytoma Cells , 1999, Journal of neurochemistry.
[33] V. Ramakrishnan,et al. Investigation of PAR-1-type thrombin receptors in rat glioma C6 cells with a novel monoclonal anti-PAR-1 antibody (Mab COR7-6H9) , 1998, Journal of neurocytology.
[34] G. Reiser,et al. Co-existence of two types of [Ca2+]i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells , 1998, Neuroscience.
[35] R. Kalff,et al. Functional thrombin receptor PAR1 in primary cultures of human glioblastoma cells , 1998, Neuroreport.
[36] P. Henklein,et al. Signaling effects of α‐thrombin and SFLLRN in rat glioma C6 cells , 1996 .
[37] J. Bockaert,et al. Secretion of Protease Nexin-1 by C6 Glioma Cells Is under the Control of a Heterotrimeric G Protein, Go1* , 1996, The Journal of Biological Chemistry.
[38] N. Kawai,et al. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. , 1996, Journal of neurosurgery.
[39] C. Deschepper,et al. Production of thrombin and antithrombin III by brain and astroglial cell cultures. , 1991, Brain research. Molecular brain research.
[40] M. Nishibori,et al. The effects of stimulating protease-activated receptor-1 and -2 in A172 human glioblastoma , 2009, Journal of Neural Transmission.
[41] T. Schallert,et al. Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models. , 2005, Acta neurochirurgica. Supplement.
[42] T. Yoshimine,et al. Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains , 2005, Journal of Neuro-Oncology.
[43] R. Kaufmann,et al. Thrombin has a bimodal effect on glioma cell growth. , 1997, British Journal of Cancer.
[44] H. Haller,et al. Signaling effects of alpha-thrombin and SFLLRN in rat glioma C6 cells. , 1996, Journal of neuroscience research.